biuro@scopefluidics.com
+48 22 376 21 14
About
Team
Our offer
Knowledge base
News
Investor relations
Contact
biuro@scopefluidics.com
+48 22 376 21 14
About
Team
Our offer
Knowledge base
News
Investor relations
Contact
biuro@scopefluidics.com
+48 22 376 21 14
Tag
home
28
Apr
Scope Fluidics S.A. completes certification clinical trials for its SARS-CoV-2 panel and commences certification clinical trials for its MRSA/MSSA panel
28.04.2022
db
Uncategorized
Read More
28
Oct
BacterOMIC system for identifying antibiotic resistance has obtained the European CE IVD marking approval
28.10.2021
Mateusz
Uncategorized
Read More
24
Sep
Scope Fluidics unveils plans for the PCR|ONE and BacterOMIC projects
24.09.2021
Mateusz
Uncategorized
Read More
30
Sep
Scope Fluidics: BacterOMIC system on the run-up to the medical diagnostics market authorization
30.09.2021
Mateusz
Uncategorized
Read More
Search
Text Widget
Nulla vitae elit libero, a pharetra augue. Nulla vitae elit libero, a pharetra augue. Nulla vitae elit libero, a pharetra augue. Donec sed odio dui. Etiam porta sem malesuada magna mollis euismod.
Recent Comments
Tag Cloud
home
×
Recent Comments